May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Dose Effects of Mitomycin C (MMC) on Corneal Scarring and TGFβ Induced Myofibroblast Differentiation
J. V. Jester; D. Brown; M. Farid; R. F. Steinert; A. Wahlert; D. W. Kim; L. Lam; C. Nien Shy
Author Affiliations & Notes
  • J. V. Jester
    The Eye Institute, University of California, Irvine, Orange, California
  • D. Brown
    The Eye Institute, University of California, Irvine, Orange, California
  • M. Farid
    The Eye Institute, University of California, Irvine, Orange, California
  • R. F. Steinert
    The Eye Institute, University of California, Irvine, Orange, California
  • A. Wahlert
    The Eye Institute, University of California, Irvine, Orange, California
  • D. W. Kim
    The Eye Institute, University of California, Irvine, Orange, California
  • L. Lam
    The Eye Institute, University of California, Irvine, Orange, California
  • C. Nien Shy
    The Eye Institute, University of California, Irvine, Orange, California
  • Footnotes
    Commercial Relationships  J.V. Jester, None; D. Brown, None; M. Farid, None; R.F. Steinert, None; A. Wahlert, None; D.W. Kim, None; L. Lam, None; C. Nien Shy, None.
  • Footnotes
    Support  NIH Grant EY07348 and EY016663, Support Grant from RPB, The Skirball Program for Molecular Ophthalmology and the Discovery Eye Foundation.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2937. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Dose Effects of Mitomycin C (MMC) on Corneal Scarring and TGFβ Induced Myofibroblast Differentiation
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      J. V. Jester, D. Brown, M. Farid, R. F. Steinert, A. Wahlert, D. W. Kim, L. Lam, C. Nien Shy; Dose Effects of Mitomycin C (MMC) on Corneal Scarring and TGFβ Induced Myofibroblast Differentiation. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2937. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : MMC treatment of photorefractive keratectomy (PRK) wounds reduces corneal scarring and haze through unknown mechanisms. The purpose of this study was to determine the concentration effects of MMC on the development of corneal haze, scarring, and the ability of keratocytes to differentiate to myofibroblasts.

Methods: : Immediately following 9 diopter PRK, rabbits were treated with varying concentrations of MMC from 0.02% to 0.00002% for 10 seconds. Rabbits were then evaluated for epithelial regeneration by fluorescein staining, development of corneal haze by in vivo confocal microscopy, and stromal scarring by ex vivo 2-photon second harmonic generation (SHG). Ability of rabbit keratocytes to differentiate to corneal myofibroblasts was evaluated by treating cultured keratocytes previously exposed to MMC with 5 ng/ml of TGFβ. Keratocyte responses were then evaluated at various times by immunostaining, western blotting and RT-PCR to measure cell proliferation, cycle entry, DNA repair, expression of alpha smooth muscle actin (α-SM) and macrophage chemotactic protein 1 (MCP-1).

Results: : No effect of MMC was detected on corneal epithelial regeneration. MMC at 0.02% significantly reduced (p<0.05) peak corneal haze and showed no significant difference to baseline levels by 8 weeks after injury. MMC at 0.002% showed significantly greater haze compared to 0.02%, but returned to baseline levels by 12 weeks. Doses of MMC below 0.002% were not significantly different from vehicle treated eyes. At 12 weeks after injury, eyes treated with 0.02% MMC showed a significant decrease in corneal scarring (p < 0.05) as measured by SHG compared to other groups. Treatment of keratocytes with 0.02% MMC in culture resulted in keratocyte cell death, while lower concentrations either blocked cell proliferation in response to TGFβ or delayed cell division. Interestingly, 0.002% MMC and below significantly increased cell cycle entry in association with nuclear staining for H2AX, a recombination protein associated with DNA repair. Finally, while MMC treatment greatly enhanced TGFβ stimulated α-SM mRNA, intermediate doses blocked myofibroblast differentiation and down-regulated MCP-1 mRNA expression.

Conclusions: : Keratocytes exposed to doses of MMC that do not inhibit corneal scarring and haze show inhibition of TGFβ induced myofibroblast differentiation, increased cell cycle entry associated with DNA repair and decreased MCP-1 expression. These findings suggest that MMC effects are not solely related to keratocyte apoptosis or inhibition of cell proliferation.

Keywords: cornea: stroma and keratocytes • refractive surgery • wound healing 
© 2008, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept